Manufactured by:ProteoGenix
Save 20%RUO

Recombinant Human APMAP, N-His

Recombinant Human APMAP, N-His from ProteoGenix; catalogue ARO-P13085; research use only.

SKU:
ABM143524-1
Manufacturer SKU
ARO-P13085
Product type
Recombinant Proteins
Expression systemProkaryotic expression

Manufacturer provenance

Manufactured by:
ProteoGenix
Sold by:
ABMIUM
Fulfilled from:
Manufacturer facility or confirmed fulfilment location

Know who made it. See the evidence. Buy through one marketplace.

Product description

Introduction

Recombinant Human APMAP (Adipocyte Plasma Membrane-Associated Protein) is a protein that is encoded by the APMAP gene and is involved in various cellular processes. It is a highly conserved protein found in humans and other mammals, and has been extensively studied for its structure, activity, and potential applications in various fields of research.

Structure of Recombinant Human APMAP

The APMAP gene encodes a protein of 141 amino acids, with a predicted molecular weight of approximately 16 kDa. The protein consists of a signal peptide, a hydrophobic transmembrane domain, and a cytoplasmic region. The cytoplasmic region contains a proline-rich domain and a C-terminal PDZ-binding motif, which are important for its function.

Recombinant Human APMAP is produced through genetic engineering techniques, using recombinant DNA technology. The protein is expressed in a host cell, typically E. coli, and then purified using various chromatography techniques. The purified protein is highly stable and retains its biological activity.

Activity of Recombinant Human APMAP

APMAP has been shown to play a role in various cellular processes, including lipid metabolism, cell adhesion, and cytoskeleton organization. It is primarily expressed in adipocytes, where it localizes to the plasma membrane. Studies have also shown its expression in other tissues, such as the liver, kidney, and brain.

One of the key functions of APMAP is its involvement in lipid metabolism. It has been shown to interact with various enzymes involved in lipid metabolism, such as phospholipase A2 and diacylglycerol kinase, and regulate their activity. This suggests a potential role for APMAP in the regulation of lipid homeostasis and obesity.

APMAP has also been implicated in cell adhesion, as it interacts with the extracellular matrix protein fibronectin. This interaction may play a role in cell migration and tissue development. Additionally, APMAP has been shown to regulate the organization of the actin cytoskeleton, which is important for cell movement and shape.

Applications of Recombinant Human APMAP

The potential applications of Recombinant Human APMAP are vast, due to its diverse functions and interactions. One potential application is in the study of lipid metabolism and obesity. APMAP has been shown to regulate lipid metabolism and may serve as a potential therapeutic target for obesity and related metabolic disorders.

APMAP’s role in cell adhesion and cytoskeleton organization also makes it a potential target for cancer research. Aberrant cell adhesion and cytoskeleton organization are hallmarks of cancer, and APMAP’s involvement in these processes may provide new insights into cancer development and potential therapeutic interventions.

In addition, APMAP has been shown to interact with various proteins involved in signal transduction, suggesting a potential role in regulating cellular signaling pathways. This makes it a promising target for drug discovery and development.

Conclusion

In summary, Recombinant Human APMAP is a highly conserved protein with diverse functions and interactions. Its structure and activity have been extensively studied, and it has shown potential applications in various fields of research, including lipid metabolism, cell adhesion, and cancer. Further research on APMAP may provide valuable insights into its role in various cellular processes and its potential as a therapeutic target.

ProteoGenix catalogue number ARO-P13085. For research use only.

Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 27.79 kDa; Fragment: Glu62-Leu289; Buffer: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol..

Available configurations: 50ug, 100ug, 1mg.

Download the manufacturer datasheet

Key facts & specifications
Also known as
Protein BSCv, APMAP, Adipocyte plasma membrane-associated protein, C20orf3
Host species
E. coli
Source organism
Human
Molecular weight
27.79 kDa
Sequence fragment
Glu62-Leu289
Sequence
ESPIDPQPLSFKEPPLLLGVLHPNTKLRQAERLFENQLVGPESIAHIGDVMFTGTADGRVVKLENGEIETIARFGSGPCKTRDDEPVCGRPLGIRAGPNGTLFVADAYKGLFEVNPWKREVKLLLSSETPIEGKNMSFVNDLTVTQDGRKIYFTDSSSKWQRRDYLLLVMEGTDDGRLLEYDTVTREVKVLLDQLRFPNGVQLSPAEDFVLVAETTMARIRRVYVSGL
Technical note
For research use only.
Identifiers & database references
Manufacturer SKU
ARO-P13085
UniProt accession
Q9HDC9
Storage, stability & shipping
Storage conditions
4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection)
Shipped at
Dry Ice
Compliance & documents
ISO certifications
ISO 9001:2023, ISO 14001: 2023
Datasheet
Open datasheet
Frequently asked questions
Who manufactured this product?

This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.

Can ABMIUM ship this product internationally?

ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.

Can I check suitability before ordering?

Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.

Is this product for clinical use?

Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.

ProteoGenix
£185.00£148.00